Skip to main content
Caplight Logo









Epinex Diagnostics, Inc.

Epinex Diagnostics, Inc.

Private
Tustin, CaliforniaHealthcare & Life Scienceshttps://www.epinex.com/

Last Round

Private Equity

Mar 1, 2013

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Epinex Diagnostics, Inc. is a medical device company that develops rapid diagnostic tests for diabetes monitoring, kidney health, and coagulation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingmedical devicechronic disease managementover-the-counter diagnosticsOTC testingglycated albumin monitoringmicrofluidicsimmunoassayprothrombin time testPT-INRurine albumin creatinine ratioACR testdigital healthhome health monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epinex Diagnostics, Inc. Comparables

Compare Epinex Diagnostics, Inc. with similar companies based on industry and business-model similarity.

Epinex Diagnostics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Modality Dx
80%
Micropoint Biotechnologies
79%
DxGen Corp.
79%

Epinex Diagnostics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 1, 2013

Key People

Founding team and executive leadership

Asad Zaidi

CEO and President

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 131% MoM.

  • Jun 21, 2026

    Monthly visitors increased 57% MoM.

Epinex Diagnostics, Inc. Filings

Explore SEC and related filing metadata, where available.

Epinex Diagnostics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epinex Diagnostics, Inc.'s valuation, stock price, and market status.

Is Epinex Diagnostics, Inc. a public or private company?

Epinex Diagnostics, Inc. is a private company.

What is the current stock price of Epinex Diagnostics, Inc.?

Epinex Diagnostics, Inc. is a private company with no public stock price. Caplight tracks Epinex Diagnostics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Epinex Diagnostics, Inc. worth (valuation)?

Valuation information for Epinex Diagnostics, Inc. is not publicly available.

Can I buy Epinex Diagnostics, Inc. stock?

Epinex Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epinex Diagnostics, Inc.'s last funding round?

Epinex Diagnostics, Inc.'s most recent funding round was Private Equity on March 1, 2013.

Who are the main investors in Epinex Diagnostics, Inc.?

Investor information for Epinex Diagnostics, Inc. is not publicly disclosed.

Will Epinex Diagnostics, Inc. IPO soon?

No public IPO plans have been announced for Epinex Diagnostics, Inc..

How can I track Epinex Diagnostics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epinex Diagnostics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTustin, California
Employee Range16
Year Founded2002
Last FundingMar 1, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?